QQ客服 官方微博 反馈留言

	Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review
	He, Wan[1]; Zou, Chang[2]; Tian, Zhongkai[1]; Tan, Wenyong[1]; Shen, Weixi[3]; Chen, Jinghua[1]; Liu, Liping[4]; Xu, Ruilian[1]
	2017
卷号	10页码:67
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4304639
专题	暨南大学
作者单位	1.[1]Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Oncol, Room 329,3-F,Block 2,1017 Dongmen North Rd, Shenzhen, Guangdong, Peoples R China 2.[2]Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Clin Med Res Ctr, Shenzhen, Peoples R China 3.[3]Southern Med Univ, Shenzhen Hosp, Dept Oncol, Shenzhen, Peoples R China 4.[4]Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Hepatobiliary & Pancreat Surg, Room 111 21-F,Surgical Bldg,1017 Dongmen North Rd, Shenzhen, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	He, Wan[1],Zou, Chang[2],Tian, Zhongkai[1],et al. Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review[J],2017,10:67.
APA	He, Wan[1].,Zou, Chang[2].,Tian, Zhongkai[1].,Tan, Wenyong[1].,Shen, Weixi[3].,...&Xu, Ruilian[1].(2017).Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review.,10,67.
MLA	He, Wan[1],et al."Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review".10(2017):67.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。